Addus HomeCare (NASDAQ:ADUS) Announces Quarterly Earnings Results

Addus HomeCare (NASDAQ:ADUS) released its quarterly earnings data on Monday. The company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24, Briefing.com reports. The firm had revenue of $280.70 million for the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period last year, the firm earned $0.84 earnings per share.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock traded up $1.84 during trading hours on Wednesday, reaching $106.43. The company had a trading volume of 7,342 shares, compared to its average volume of 123,152. The firm has a market cap of $1.74 billion, a PE ratio of 27.24, a price-to-earnings-growth ratio of 1.94 and a beta of 0.96. Addus HomeCare has a one year low of $78.35 and a one year high of $106.43. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. The business has a fifty day simple moving average of $98.73 and a 200 day simple moving average of $92.61.

Analyst Ratings Changes

A number of research firms recently commented on ADUS. Royal Bank of Canada reissued an “outperform” rating and issued a $102.00 price target on shares of Addus HomeCare in a research report on Thursday, February 29th. William Blair reiterated an “outperform” rating on shares of Addus HomeCare in a report on Monday, February 5th. Stephens restated an “overweight” rating and set a $115.00 price target on shares of Addus HomeCare in a report on Tuesday. Oppenheimer reaffirmed an “outperform” rating and issued a $118.00 price objective on shares of Addus HomeCare in a research report on Tuesday, March 26th. Finally, Bank of America boosted their target price on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $106.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.